SK32097A3 - Aminoalkyl-a acylaminoalkyl ethers, preparation method thereof and their use as antagonizing agents of bradykinin receptors - Google Patents

Aminoalkyl-a acylaminoalkyl ethers, preparation method thereof and their use as antagonizing agents of bradykinin receptors Download PDF

Info

Publication number
SK32097A3
SK32097A3 SK320-97A SK32097A SK32097A3 SK 32097 A3 SK32097 A3 SK 32097A3 SK 32097 A SK32097 A SK 32097A SK 32097 A3 SK32097 A3 SK 32097A3
Authority
SK
Slovakia
Prior art keywords
carbon atoms
group
radical contains
radical
aryl
Prior art date
Application number
SK320-97A
Other languages
English (en)
Slovak (sk)
Inventor
Holger Heitsch
Adalbert Wagner
Klaus Wirth
Bernward Scholkens
Gerhard Nolken
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SK32097A3 publication Critical patent/SK32097A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK320-97A 1996-03-13 1997-03-11 Aminoalkyl-a acylaminoalkyl ethers, preparation method thereof and their use as antagonizing agents of bradykinin receptors SK32097A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19609827A DE19609827A1 (de) 1996-03-13 1996-03-13 Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten

Publications (1)

Publication Number Publication Date
SK32097A3 true SK32097A3 (en) 1998-01-14

Family

ID=7788139

Family Applications (1)

Application Number Title Priority Date Filing Date
SK320-97A SK32097A3 (en) 1996-03-13 1997-03-11 Aminoalkyl-a acylaminoalkyl ethers, preparation method thereof and their use as antagonizing agents of bradykinin receptors

Country Status (26)

Country Link
US (1) US6140341A (cs)
EP (1) EP0795547B1 (cs)
JP (1) JP4317597B2 (cs)
KR (1) KR970065521A (cs)
AR (1) AR006189A1 (cs)
AT (1) ATE192738T1 (cs)
AU (1) AU1621797A (cs)
BR (1) BR9701267A (cs)
CA (1) CA2199771A1 (cs)
CZ (1) CZ76697A3 (cs)
DE (2) DE19609827A1 (cs)
DK (1) DK0795547T3 (cs)
ES (1) ES2148858T3 (cs)
GR (1) GR3033415T3 (cs)
HR (1) HRP970138A2 (cs)
HU (1) HUP9700566A1 (cs)
ID (1) ID16217A (cs)
IL (1) IL120427A0 (cs)
NO (1) NO971136L (cs)
PL (1) PL318923A1 (cs)
PT (1) PT795547E (cs)
SI (1) SI0795547T1 (cs)
SK (1) SK32097A3 (cs)
TR (1) TR199700184A2 (cs)
TW (1) TW363891B (cs)
ZA (1) ZA972129B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR070950A1 (es) 2007-11-01 2010-05-19 Acucela Inc Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
SMT202200154T1 (it) 2017-11-24 2022-05-12 Pharvaris Netherlands B V Nuovi antagonisti del recettore della bradichinina b2
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
KR20240039185A (ko) 2021-08-05 2024-03-26 파르바리스 게엠베하 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
HRP20260166T1 (hr) 2022-03-25 2026-03-27 Pharvaris Gmbh Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5288725A (en) * 1992-10-15 1994-02-22 Merck & Co., Inc. Pyrroloquinoline Bradykinin antagonist
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CN1168667A (zh) * 1994-10-27 1997-12-24 藤沢药品工业株式会社 用作缓激肽拮抗剂的吡啶并嘧啶酮,喹啉和稠合的n-杂环化合物
FR2735128B1 (fr) * 1995-06-07 1997-07-25 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
FR2737892B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
CA2199771A1 (en) 1997-09-13
KR970065521A (ko) 1997-10-13
ES2148858T3 (es) 2000-10-16
MX9701857A (es) 1997-09-30
NO971136D0 (no) 1997-03-12
HRP970138A2 (en) 1998-04-30
ATE192738T1 (de) 2000-05-15
EP0795547A1 (de) 1997-09-17
US6140341A (en) 2000-10-31
JPH101472A (ja) 1998-01-06
SI0795547T1 (en) 2000-10-31
AU1621797A (en) 1997-09-18
PL318923A1 (en) 1997-09-15
PT795547E (pt) 2000-10-31
DK0795547T3 (da) 2000-09-18
EP0795547B1 (de) 2000-05-10
GR3033415T3 (en) 2000-09-29
DE19609827A1 (de) 1997-09-18
DE59701617D1 (de) 2000-06-15
HUP9700566A1 (hu) 2000-08-28
ID16217A (id) 1997-09-11
HU9700566D0 (en) 1997-04-28
AR006189A1 (es) 1999-08-11
NO971136L (no) 1997-09-15
CZ76697A3 (en) 1997-10-15
BR9701267A (pt) 1999-01-12
TR199700184A2 (xx) 1997-10-21
IL120427A0 (en) 1997-07-13
JP4317597B2 (ja) 2009-08-19
ZA972129B (en) 1997-09-15
TW363891B (en) 1999-07-11

Similar Documents

Publication Publication Date Title
US7161009B2 (en) Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
KR101517154B1 (ko) Rho-키나제의 억제제로서의 치환된 이소퀴놀린 및 이소퀴놀리논 유도체
CZ76697A3 (en) Aminoalkyl- and acylaminoalkyl ethers process of their preparation and their use as antagonizing agents of bradykinin receptors
JP2003503490A (ja) インドール誘導体およびとりわけ骨粗鬆症の治療のためのそれらの使用
CZ286739B6 (en) Imidazopyridine derivative, process of its preparation and pharmaceutical preparation containing thereof
CA2254756A1 (en) Antagonists of gonadotropin releasing hormone
US20040106641A1 (en) Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
NO300271B1 (no) Pyrazolopyridin-forbindelser og farmasoytiske preparater inneholdende disse
US6211196B1 (en) Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists
CZ81097A3 (en) Heterocyclic fluoroalkyl derivatives and fluoroalkoxy derivatives, process of their preparation and their use as bradykinin antagonists
JP2004521914A (ja) インドール誘導体とGnRHアンタゴニストとしてのその使用
US6150522A (en) Antagonists of gonadotropin releasing hormone
JP2008516901A (ja) 非ペプチドブラジキニンアンタゴニストおよびそれによる医薬組成物
JP2003532616A (ja) 骨粗鬆症の治療に有用なa.o.インドール誘導体
CZ154797A3 (en) Sulfur containing heterocyclic antagonists of bradykinin, process of their preparation and medicaments containing thereof
EP0166356A2 (en) 2-Substituted-aminomethyl-1,4-benzodiazepines, process for their preparation and pharmaceutical compositions containing them
SK34993A3 (en) Propenoyl-imidazole derivatives
JPH06329637A (ja) 複素環置換フエニル酢酸誘導体類のフエニルグリシンアミド
ES2277389T3 (es) Cetonas heterociclicas como antagonistas npy 15.
MXPA97003724A (en) Heterociclic bradiquinin antagonists with sulfur content, procedure for preparation and emp
MXPA97001857A (en) Aminoalquil-eteres and acilaminoalquil-eteres, procedure for its preparation and its use as antagonists of bradiquin receptors
PT89356B (pt) Processo para a preparacao de derivados da 2-amino-tetra-hidro-isoquinolina e de composicoes farmaceuticas contendo os mesmos
MXPA97002028A (es) Antagonistas de bradiquinina heterociclicos, sustituidos con fluoroalquilo y fluoroalcoxi, procedimientos para su preparacion y su utilizacion